There is no deviation or variation in the utilization of funds raised through preferential allotments.
Funds raised via preferential allotments have been fully utilized as on September 30, 2026.
There are no outstanding or unutilized amounts for any preferential allotment as of the report date.
Audit Committee Review
The audit committee reviewed this statement in their meeting held on November 14, 2026.
Fund Raising Details
Total Amount Raised: ₹37,35,44,250/-
Breakdown of fund raising components:
Allotment of 36,44,000 equity shares on June 28, 2023: ₹17,49,12,000/-
Allotment of 13,74,000 share warrants on June 28, 2023: ₹1,64,88,000/-
Amount received upon conversion of 10,74,000 warrants into equity shares on January 29, 2024: ₹3,86,64,000/-
Amount received upon conversion of 3,00,000 warrants into equity shares on August 8, 2024: ₹1,08,00,000/-
Additionally, 14,00,000 equity shares were allotted to a promoter at an issue price of ₹48 per share (including premium of ₹38 per share) upon conversion of unsecured loans into equity shares: Aggregate ₹6,72,00,000/- (no funds received as it was a conversion of loan)
Amount received via allotment of 3,55,000 equity shares on December 25, 2024: ₹3,19,50,000/-
Amount received via allotment of 5,95,000 equity share warrants on December 25, 2024: ₹1,33,87,500/-
Amount received via allotment of 6,89,000 equity shares on December 31, 2024: ₹6,20,10,000/-
Amount received via allotment of 4,53,225 equity share warrants on December 31, 2024: ₹1,01,97,563/-
Amount received upon conversion of 1,90,225 warrants into equity shares on May 12, 2026: ₹1,28,40,187/-
Amount received upon conversion of 34,000 warrants into equity shares on June 30, 2026: ₹22,95,000/-
Objects of Fund Raising
As per EGM on June 14, 2023: Towards completing the state-of-the-art facility/plant near Vijayawada, meeting working capital requirement, repayment of unsecured loans, and for other general corporate purposes.
As per EGM on December 14, 2024: Repayment of unsecured loans, towards working capital requirements, fulfilling additional capex requirements, and for other general corporate purposes.
No modification to the objects; original allocation remains unchanged.
Additional Information
Monitoring Agency: Not Applicable
Since there is no deviation, no explanation for deviation, shareholder approval date, or comments from audit committee or auditors are provided.
Funds utilized till September 30, 2026: ₹37,35,44,250/- (fully utilized according to original objects).
